Basel Medical Group Ltd (BMGL) Form 6-K — Oct 13, 2026
Basel Medical Group Ltd (Nasdaq: BMGL) closed a registered direct offering on October 9, 2026, selling 6,000,000 units at US$1.33 per unit for gross proceeds of US$7.98 million and estimated net proceeds of approximately US$7.28 million, with Cathay Securities as exclusive placement agent. The offering nearly quintupled the share count: shares outstanding jumped from 1,582,111 to 7,582,111, and investors also received 6,000,000 five-year common warrants exercisable at US$1.463 or on a zero-cash basis, meaning full exercise would double shares again without any additional cash to the company.
Key figures
- Gross Proceeds
- 7980000
- Offering Price
- 1.33
- Shares Offered
- 6000000
- Shares Outstanding
- 7582111
- Lockup Days
- 180
- Net Proceeds
- approximately US$7.28 million
- Warrant Term
- 5 years
- Zero Cash Exercise
- Yes
- Exercise Price Floor
- Yes
- Warrant Exercise Price
- US$1.463 (110% of offering price)
- Shares Outstanding Prior
- 1582111
- Common Warrants Outstanding
- 6000000
- Warrant Exercise Price Floor
- US$1.463
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.